The SCID-hu mouse: An in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS

Seminars in Immunology

Volumn 8, Issue 4, 1996, Pages 215-221

  Jamieson, Beth D ^a   Aldrovandi, Grace M ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Animal models; Gene therapy; HIV; SCID hu

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; GENE; GENE THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MOUSE; NONHUMAN; PATHOGENESIS; REVIEW; STEM CELL;

EID: 0030220831     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0027     Document Type: Review

References (43)

1. 1. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL (1988) The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639
2. 2. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259
3. 3. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM (1990) Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172:1055-1063
4. 4. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM (1988) Infection of SCID-hu mouse by HIV-1. Science 242:1684-1686
5. 5. Aldrovandi GM, Feuer G, Gao L, Kristeva M, Chen ISY, Jamieson B, Zack JA (1993) HIV-1 infection of the SCID-hu mouse: An animal model for virus pathogenesis. Nature 363:732-736
6. 6. Jamieson BD, Aldrovandi GM, Planelles V, Jowett JBM, Gao L, Bloch LM, Chen ISY, Zack JA (1994) Requirement of HIV-1 nef for in vivo replication and pathogenesis. J Virol 68:3478-3485
7. 7. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H (1993) HIV induces thymus depletion in vivo. Nature 363:728-736
8. 8. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J, Fox CH, Fauci AS (1993) Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 178:1151-1163
9. 9. Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H (1994) Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med 179:513-522
10. 10. Rosenzweig M, Clark DP, Gaulton GN (1993) Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7:1601-1605
11. 11. Papiernik M, Brossard Y, Mulliez N, Roume J, Brechot C, Barin F, Goudeau A, Bach J-F, Griscelli C, Henrion R, Vazeux R (1992) Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89:297-301
12. 12. Jamieson BD, Pang S, Aldrovandi GM, Zha J, Zack JA (1995) in vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol 69:6259-6264
13. 13. Kaneshima H, Su L, Bonyhadi ML, Connor RI, Ho DD, McCune JM (1994) Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol 68:8188-8192
14. 14. Kollmann TR, Kim A, Pettoello-Mantovani M, Hachamovitch M, Rubinstein A, Goldstein MM, Goldstein H (1995) Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol 154:907-921
15. 15. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA (1985) Production of acquired immunodeficiency syndrome - associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284-291
16. 16. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Ymters HV, Chen ISY(1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822
17. 17. Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen ISY (1992) Rapid generation of sequence variation during primary HIV-1 infection. AIDS 6:453-460
18. 18. Trono D (1995) HIV accessory proteins: Leading roles for the supporting cast. Cell 82:189-192
19. 19. Kestler HW III, Ringler DJ, Kazuyasu M, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662
20. 20. Daniel MD, Kirchoff F, Czajak SC, Sehgal PK, Desrosiers RC (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941
21. 21. Aldrovandi GM, Zack JA (1996) Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol 70:1505-1511
22. 22. Saksela K, Cheng G, Baltimore D (1995) Proline-rich (P X X P) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14:484-491
23. 23. Gibbs JS, Lackner AA, Lang SM, Simon MA, Sehgal PK, Daniel MD, Desrosiers RC (1995) Progression to AIDS in the absence of a gene for vpr or vpx. J Virol 69:2378-2383
24. 24. Hoch J, Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Dittmer U, Hunsmann G, Fuchs D, Muller J, Sopper S, Fleckenstein B, Uberla KT (1995) vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol 69:4807-4813
25. 25. Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprecht RM (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825
26. 26. Gary RF (1989) Potential mechanisms for the cytopathic properties of HIV. AIDS 3:683-694
27. 27. Sodroski J, Goh WC, Rosen C, Dayton A, Terwillinger E, Haseltine W (1986) A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321:412-417
28. 28. Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG (1986) Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 323:725-728
29. 29. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348
30. 30. Tanneau R, McChesneyM, Lopez O, Sonsonetti P, Montagnier L, Riviere Y (1990) Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: Evidence for antibody-dependent cellular cytotoxicity in vivo. J Infect Dis 162:837-843
31. 31. Laurent-Crawford AG, Drust B, Muller S, Riviere Y, Rey-Cuille MA, Bechet JM, Montagnier L, Hovanessian AG (1991) The cytopathic effect of HIV is associated with apoptosis. Virology 185:829-839
32. 32. Terai C, Kornbluth RS, Pauza CD, Richmann DD, Carson DA (1991) Apoptosis as a mechanism of cell death in cultured lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710-1715
33. 33. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM (1995) HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2:25-36
34. 34. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
35. 35. Hotz AH, Gong J, Traganos F, Darzynkiewicz A (1994) Flow cytometric detection of apoptosis: Comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15:237-244
36. 36. Gorczyca W, Gong J, Darzynkiewicz Z (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945-1951
37. 37. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor assays. Cancer Res 53:3186-3192
38. 38. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV (1994) A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 170:145-157
39. 39. Fadok VA, Voelker DR, Campbell PAS, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216
40. 40. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420
41. 41. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39-51
42. 42. Akkina RK, Rosenblatt JD, Campbell AG, Chen ISY, Zack JA (1994) Modeling human stem cell gene therapy in the SCID-hu mouse. Blood 84:1393-1398
43. 43. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer. Biotechniques 7:980-990